Redesigned CD40 Agonist Antibody 2141-V11 Demonstrates Systemic Tumor Regression in Early Clinical Trials
The landscape of cancer immunotherapy has been fundamentally altered by the publication of new clinical...
Knowledge and News for the Global Fight Against Cancer.
The landscape of cancer immunotherapy has been fundamentally altered by the publication of new clinical...
A newly published study has confirmed the presence of Echinococcus multilocularis, a highly pathogenic tapeworm,...
In a discovery that challenges decades of established physiological dogma, researchers at the Mayo Clinic...
In the complex landscape of oncology, tumor suppressor genes have long been characterized as the...
A research team at the Japan Advanced Institute of Science and Technology (JAIST) has announced...
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy...
The global oncology community has long grappled with the dual-edged sword of chemotherapy, a treatment...
New research from the University of South Australia has identified a significant and previously underestimated...
The Australian healthcare system currently faces a significant disconnect between evidence-based clinical guidelines and the...
Researchers at the University of California, Santa Barbara (UCSB) have announced a significant milestone in...